Empowering Patients to Choose the Right HIV PrEP for Them
Failed to add items
Sorry, we are unable to add the item because your shopping cart is already at capacity.
Add to Cart failed.
Please try again later
Add to Wish List failed.
Please try again later
Remove from wishlist failed.
Please try again later
Adding to library failed
Please try again
Follow podcast failed
Please try again
Unfollow podcast failed
Please try again
Empowering Patients to Choose the Right HIV PrEP for Them
-
Narrated by:
-
By:
About this listen
In this episode, Jona Tanguay, MMSc, PA-C, AAHIVS discusses considerations to review with patients to empower them to make their own informed choices in PrEP selection, including:
- Leveraging PrEP options with unique dosing schedules and/or routes such as long-acting cabotegravir and on-demand 2-1-1 FTC/TDF
- Differences in adverse effect profiles between 4 PrEP options
- Potential for HIV resistance
- Requirements for compliance and monitoring
- Evidence in populations with various acquisition behaviors
- Drug interaction implications
Faculty:
Jona Tanguay, MMSc, PA-C, AAHIVS
Health Care Provider and HIV Specialist
Whitman-Walker Health
Vice President for Education, GLMA: Health Professionals Advancing LGBTQ Equality
Clinical Instructor, Yale University School of Nursing
Washington, DC
Link to full program: https://bit.ly/41WF54o
adbl_web_global_use_to_activate_T1_webcro805_stickypopup
No reviews yet